Laura L. Tenner, MD
Hematology & Oncology Physician · Omaha, NE
Laura L. Tenner, MD is a hematology & oncology physician with a practice address in Omaha, Nebraska, and NPI 1366601924, issued on Jun 8, 2008. Check the license on the Nebraska Board of Medicine and Surgery; the Medicare figures below come from public CMS files.
- Name
- Laura L. Tenner
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License numbers
- Q0578 TX
11014025A IN
Self-reported in NPPES; status is on the state search - Practice location
- 986840 Nebraska Medical Center, Omaha, NE 68198
- Phone
- (402) 559-8500
- Enumerated
- Jun 8, 2008
- Record last updated
- Jun 2, 2026
- Medicaid ID
- 337188201 TX
- Medicare enrollment
- Enrolled (PECOS I20210415000876); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 80 in Nebraska → Look up another NPI →
Also registered at 986840 Nebraska Medical Center
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Snegha Ananth, MBBSHematology & Oncology Physician1629508817
- Meghana Kesireddy, MBBSInternal Medicine Physician1184148868
Verify Laura L. Tenner in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNebraska Board of Medicine and SurgeryCheck the board
- 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
64% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
313 Medicare Part D claims for 62 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 11% of claims. 18 claims were for opioids.
Most prescribed
- Ondansetron Hcl40 claims
- Prochlorperazine Maleate36 claims
- Dexamethasone34 claims
- Potassium Chloride28 claims
- Eliquis23 claims
- Famotidine16 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $249.67
2 payments; by number, the most common kind was food and beverage; the largest payer was AstraZeneca Pharmaceuticals LP. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Unmc PhysiciansOmaha, NE
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Laura L. Tenner among 80 hematology & oncology physician records in Nebraska
Laura L. Tenner, MD is one of 80 hematology & oncology physician records with a practice address in Nebraska. 81% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2008, is newer than 75% of them.
- NPI issued2008 · 75% of these records are older, 20% newer
- In a Medicare fileYes · 81% of these records are
- In the CMS Doctors and Clinicians fileYes · 73% of these records are
- Graduated2007 · median 1997 among the 58 with a school on file
- Record last updated2026 · 53% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Nebraska practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Nebraska
There are 80 hematology & oncology physician records in Nebraska.
All 80 in Nebraska → Every provider in Omaha → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Mojtaba Akhtari, M.D.Omaha, NE 681981922286954
- James Armitage, MDOmaha, NE 681981073579090
- Philip Bierman, MDOmaha, NE 681981952369852
- Robert Bociek, MDOmaha, NE 681981942268768
- Marcel Devetten, MDOmaha, NE 681981144278946
- Apar Kishor Ganti, MDOmaha, NE 681981124076997
- Jean Grem, MDOmaha, NE 681981609824424
- William Haire, MDOmaha, NE 681981225086929
Common questions
What is Laura L. Tenner, MD's NPI number?
Laura L. Tenner, MD's National Provider Identifier (NPI) is 1366601924, issued on Jun 8, 2008. An NPI identifies a provider in billing; it is not a license.
Where is Laura L. Tenner, MD located?
The NPPES record lists a practice address at 986840 Nebraska Medical Center, Omaha, NE, 68198. Phone: (402) 559-8500. Providers update this record themselves, so call before visiting.
How can I verify Laura L. Tenner, MD's license?
Search the Nebraska Board of Medicine and Surgery at https://www.nebraska.gov/LISSearch/search.cgi. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Laura L. Tenner, MD prescribe under Medicare Part D?
In 2024, Laura L. Tenner, MD had 313 Medicare Part D claims for 62 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.